ClarityCare said Monday it raised $16.5 million in a Series A round led by Headline, the venture firm, as the San Francisco startup pushes its AI agents deeper into the prior authorization process at health plans. Arthur Ventures and FJ Labs joined as new investors, and existing backers Maverick Ventures, firstminute capital, Top Harvest Capital and Transpose Platform also took part.
The exact size of the round depends on whom you ask. Axios Pro's preview put it at $16.28 million, while the company and MedCity News reported $16.5 million. Several deal trackers list $16.3 million.
Why federal rules are driving demand
The timing owes much to Washington. The Centers for Medicare & Medicaid Services' interoperability and prior authorization final rule, known as CMS-0057-F, set decision deadlines beginning Jan. 1, 2026: 72 hours for expedited requests and seven calendar days for standard requests involving non-drug items and services, according to a CMS fact sheet. The rule also requires payers to give specific reasons for denials. Public reporting of prior authorization metrics was due by March 31, 2026.
Hermine Tranie, ClarityCare's co-founder and chief executive, told MedCity News by email on Oct. 27 that "Medicaid and Medicare Advantage plans face the most pressure from the new CMS rules."
What Electra does
ClarityCare sells AI agents under the name Electra, which run inside health plans, payers and third-party administrators. The company says Electra handles prior authorization from intake to decision support. It reads and organizes incoming requests, checks them against clinical criteria and plan benefits, and produces an auditable rationale. On the administrative side, it drafts provider letters and faxes and creates or updates cases in utilization management systems.
There is a boundary, the company says. Electra can approve a request or escalate it, but "never issues a denial," and clinical decisions remain with humans. ClarityCare's website lists SOC 2 Type II and HIPAA compliance and says customers can go live within weeks. All of that is the company's own description.
Tranie was candid about the appeal of the work. "We're an AI services company, and we're here to solve the unsexiest problems in the system: the ones most patients never see, and never should," she said in the company's announcement.
Customers and the performance claims
MedCity News reported that ClarityCare has seven customers, with workflows that touch 6 million people across that base.
The results being cited are striking but loosely sourced. In a LinkedIn post captured Oct. 28, Mathias Schilling of Headline wrote that Electra helped one partner cut prior authorization wait times "from 12 days to just 2." A post from Tranie said a prior authorization that used to take 12 days "now takes 5 minutes." Neither post specifies the timing or context of the measurement, and neither figure has been independently verified. The two numbers also describe different outcomes, which may reflect different workflows or different customers.
Schilling, Headline's co-founder and managing partner, said in the announcement: "Hermine and Alex are rare founders who combine exceptional execution with a deep understanding of one of healthcare's most complex challenges."
Where the money goes
ClarityCare said it will hire in engineering and clinical roles as well as sales, build new products and expand in the government sector. It is also looking for a new Bay Area office. MedCity News reported that the money will go toward growing its health plan administration AI platform and scaling integrations and go-to-market efforts.
The company said it has raised nearly $20 million in total. MedCity put the figure at $19.8 million, and Caplight's profile shows $19.91 million. A company newsletter dated April 6, 2026, said it closed a $3.5 million round in October 2025 and called it pre-seed, though Tranie's personal site describes the same round as seed. Backers of that round included Maverick Capital (named as Maverick Ventures in the current announcement), firstminute capital, Top Harvest Capital, Entrepreneurs First and Transpose Platform.
Alexandru Andrei is the company's chief technology officer and a two-time founder, according to its team page. Tranie's bio lists a research background at MIT and earlier data science roles at Feelmore Labs and WhiteLab Genomics. Caplight's data showed headcount growing modestly, from 18 to 21 employees, though that snapshot may already be stale.
A crowded field
ClarityCare is not alone. Cohere Health sells utilization management and prior authorization automation to payers and references CMS-0057-F compliance support in its materials. Availity offers a FHIR-native authorization product. Caplight's comparables list also names Basys.ai and Ethermed.
What comes next
More regulation is on the way. CMS has proposed a separate rule for drugs, CMS-0062-P, issued in April 2026, with 24-hour deadlines for urgent requests and 72 hours for standard ones. If finalized, it would generally take effect in 2027. API requirements under CMS-0057-F also begin Jan. 1, 2027.
For now, ClarityCare's own to-do list is shorter: finish the hiring push and find a new office in the Bay Area.
